Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ11301132-1,48
KB11841186-0,75
PKN109,04109,060,63
Msft-0,13
Nokia5,9685,971,05
IBM1,10
Mercedes-Benz Group AG58,2258,251,06
PFE0,40
16.02.2026 14:14:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Lotus Res Rg (Australian)
Závěr k 13.2.2026 Změna (%) Změna (AUD) Objem obchodů (AUD)
1,97 -4,61 -0,10 -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.02.2026
Popis společnosti

Business Summary: Lotus Resources Limited is an advanced uranium company. The principal activities of the Company include the exploration and development of its Kayelekera Uranium Project in Malawi and Letlhakane Uranium Project in Botswana. The Company operates through four business segments and two geographical locations, being the exploration, evaluation and development of Uranium assets in Africa (comprising the geographical locations Malawi and Botswana), nickel-cobalt exploration, evaluation and development in Australia, and corporate activities in Australia. The Kayelekera Uranium Project is located in northern Malawi, Southern Africa, 52 kilometers (km) west by road from the town of Karonga. It owns a 100% interest in Letlhakane Uranium Project in Botswana. The asset is located within 50 kilometers of Francistown, a population center in Botswana.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Lotus Resources Ltd revenues increased from A$1.7M to A$3.6M. Net loss decreased 44% to A$13.8M. Revenues reflect Finance income - interest increase from A$1.6M to A$3.4M, Other income (including foreign currency increase from A$21K to A$197K. Lower net loss reflects Nickel segment loss decrease of 100% to A$40K, Corporate segment loss decrease of 65% to A$3.4M.



  • Poslední aktualizace: 16.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Group Chief Executive Officer, Managing Director, Executive DirectorChristian Behrenbruch-03.01.201703.01.2017
Group Chief Financial OfficerDarren Smith-31.07.202231.07.2022
Chief Executive Officer - Telix InternationalRaphaeel Ortiz-
Chief Executive Officer - Telix Precision MedicineKevin Richardson-11.07.2022
Group Chief Operating OfficerDarren Patti-11.03.202411.03.2024
Chief Technology OfficerPaul Schaffer-07.04.202507.04.2025
Group General CounselLena Moran-Adams-01.01.2022
Group Chief Medical OfficerDavid Cade-01.01.2024
Group Chief Development OfficerJames Stonecypher-01.01.2022
Group Chief Commercial OfficerRichard Valeix-05.12.2022